Timothy Keutzer

Chief Operating OfficeratSpero Therapeutics· In proxies 2022–2025

Pay in FY2025+39% from the year before · Spero Therapeutics stock +126.2% the same year

Timothy Keutzer was paid $1.4M in FY2025 (Dec), up 39%. Spero Therapeutics stock rose 126.2% that year.

Pay$100 in the stock at the end of FY21 → $15

Pay is from the Summary Compensation Table of each Spero Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

SPRO
Spero TherapeuticsPublic company · 4 yr
- Chief Operating Officer2022 – Present · 4 yrStock in role -92%

Roles come from the proxy statements of each company.

Activity

Pay
Spero Therapeutics COO pay rose 39% to $1.4M. The stock rose 126% in FY2025 (Dec).
DEF 14AApr 27, 2026
Pay
Spero Therapeutics COO pay fell 28% to $1.0M. The stock fell 30% in FY2024 (Dec).
DEF 14AApr 28, 2025

For the press:Download CSV Download PNG How to use our data

Two people shown as one, or a wrong number?